Pay in 4 interest-free payments of $6.14 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
Based on investigational protocol reports and the clinical trial data, most subjects begin to see measurable changes in body composition at 4 to 6 weeks on a consistent daily protocol at 300 mcg
This conclusion was drawn by measuring collagen type I levels produced by fibroblasts in a cell culture following exposure to varying concentrations of AHK
Theoretically, they operate through different mechanisms: semaglutide suppresses appetite and slows gastric emptying via GLP-1 receptors, while AOD 9604 acts on beta-3 adrenergic receptors on fat cells
Is AOD 9604 FDA-approved
Crucially, this happens without IGF-1 stimulation
AHK-Cu is frequently studied alongside GHK-Cu and other copper peptides in comparative ECM research protocols examining chain-length and metal-binding affinity differences
